Patient info Open main menu

Ranolazine Wockhardt 750mg Prolonged-Release – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
750 mg
Contains active substance:
ATC code:

Patient leaflet - Ranolazine Wockhardt 750 mg prolonged-release tablets

1. What Ranolazine Wockhardt is and what it is used for

What Ranolazine Wockhardt is

Ranolazine Wockhardt is a medicine used in combination with other medicines to treat angina pectoris, which is a chest pain or discomfort that you feel anywhere along the upper part of your body between your neck and upper abdomen, often brought on by exercise or too much activity.

You must talk to a doctor if you do not feel better or if you feel worse.

2. What you need to know before you take Ranolazine Wockhardt

Do not take Ranolazine Wockhardt:

  • if you are allergic to ranolazine or any of the other ingredients of this medicine listed in section 6 of this leaflet
  • if you have severe kidney problems
  • if you have moderate or severe liver problems
  • if you are using certain medicines to treat bacterial infections (clarithromycin, telithromycin), fungal infections (itraconazole, ketoconazole, voriconazol, posaconazol), HIV infection (protease inhibitors), depression (nefazodone) or heart rhythm disorders (e.g. quinidine, dofetilide, or sotalol).

Warnings and precautions

Talk to your doctor before taking Ranolazine Wockhardt:

  • if you have mild or moderate kidney problems
  • if you have mild liver problems
  • if you have ever had an abnormal electrocardiogram (ECG)
  • if you are elderly
  • if you have low weight (60 kg or less)
  • if you have heart failure.

Your doctor may decide to give you a lower dose or take other precautions if any of these apply to you.

Using other medicines and Ranolazine Wockhardt

Do not use the following medicines if you take Ranolazine Wockhardt:

  • certain medicines to treat bacterial infections (clarithromycin, telithromycin), fungal infections (itraconazole, ketoconazole, voriconazole, posaconazole), HIV infection (protease inhibitors), depression (nefazodone), or heart rhythm disorders (e.g. quinidine, dofetilide, or sotalol).

Tell your doctor or pharmacist before you take Ranolazine Wockhardt if you use:

  • certain medicines to treat a bacterial infection (erythromycin), or a fungal infection (fluconazole), a medicine used to prevent rejection of a transplanted organ (ciclosporin), or if you are taking some heart tablets such as diltiazem or verapamil. These medicines

    may cause an increase in the number of side effects, such as dizziness, nausea, or vomiting, which are possible side effects of Ranolazine Wockhardt (see section 4). Your doctor may decide to give you a lower dose

    • medicines to treat epilepsy or another neurologic disorder (e.g. phenytoin, carbamazepine, or phenobarbital); are taking rifampicin for an infection (e.g. tuberculosis); or are taking the herbal remedy St. John’s Wort, as these medicines may cause Ranolazine Wockhardt to be less effective
    • heart medicines containing digoxin or metoprolol, as your doctor may want to change the dose of this medicine whilst you are taking Ranolazine Wockhardt
    • certain medicines to treat allergies (e.g. terfenadine, astemizole, mizolastine), heart rhythm disorders (e.g. disopyramide, procainamide), and depression (e.g. imipramine, doxepin, amitriptyline), as these medicines may affect your ECG
    • certain medicines to treat depression (bupropion), psychosis, HIV infection (efavirenz), or cancer (cyclophosphamide)
    • certain medicines to treat high levels of cholesterol in the blood (e.g. simvastatin, lovastatin, atorvastatin). These medicines may cause muscle pain and muscle injury.

      Your doctor may decide to change the dose of this medicine while you are taking Ranolazine Wockhardt

    • certain medicines used to prevent transplanted organ rejection (e.g. tacrolimus, ciclosporin, sirolimus, everolimus) as your doctor may decide to change the dose of this medicine while you are taking Ranolazine Wockhardt.

Tell your doctor or pharmacist if you are using or have recently used or might use any other medicines.

Ranolazine Wockhardt with food and drink

Ranolazine Wockhardt can be taken with or without food. While being treated with Ranolazine Wockhardt, you should not drink grapefruit juice.

Pregnancy

You should not take Ranolazine Wockhardt if you are pregnant unless your doctor has advised you to do so.

Breast-feeding

You should not take Ranolazine Wockhardt if you are breastfeeding. Ask your doctor for advice if you are breast-feeding.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

Driving and using machines

No studies on the effects of Ranolazine Wockhardt on the ability to drive and use machines have been performed. Ask your doctor for advice about driving or using machines.

Ranolazine Wockhardt may cause side effects such as dizziness (common), blurred vision (uncommon), confusional state (uncommon), hallucination (uncommon), double vision (uncommon), coordination problems (rare), that may affect your ability to drive or use machines. If you experience these symptoms, do not drive or operate machinery until they have resolved completely.

Ranolazine Wockhardt 750mg prolonged-release tablets contain the azo colouring agent E102. This colouring agent may cause allergic reactions.

Ranolazine Wockhardt 750mg prolonged-release tablets contain lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

This medicine contains less than 1mmol sodium (23mg) per prolonged-release tablet, that is to say essentially ‘sodium-free’.

3. How to take Ranolazine Wockhardt

Always take this medicine exactly as your doctor has told you to. Check with your doctor or pharmacist if you are not sure.

Always swallow the tablets whole with water. Do not crush, suck, or chew the tablets or break them in half, as this might affect the way the medicine is released from the tablets into your body.

The starting dose for adults is one 375mg tablet twice a day. After 2−4 weeks, your doctor may increase the dose to get the right effect. The maximum dose of Ranolazine Wockhardt is 750mg twice a day.

It is important that you tell your doctor if you get side effects such as dizziness or feeling or being sick. Your doctor may lower your dose or, if this is not sufficient, stop treatment with Ranolazine Wockhardt.

PRODUCT :Ranolazine 375mg, 500mg and 750mg Prolonged-release Tablets
CUSTOMER :Wockhardt UK
FP CODE:—
PLANT LOCATION :Daman (Bhimpore)
(w)180 x (h)360mm
Adobe Illustrator CS6
Myriad Pro Regular / Bold
22nd January, 2024
R 1st PDF sent on - 25TH JAN. 2024 R 2nd PDF sent on - 29TH JAN. 2024 R 3rd PDF sent on - 30TH JAN. 2024 R 4th PDF sent on - 11TH FEB. 2026 R 5th PDF sent on - 12TH FEB. 2026

Process Black

DUMM
Y

XXXXXX/X

XXXXXX

Use in children and adolescents

Children and adolescents under 18 years old should not take Ranolazine Wockhardt.

If you take more Ranolazine Wockhardt than you should

If you accidentally take too many Ranolazine Wockhardt tablets or take a higher dose than recommended by your doctor, it is important that you tell your doctor at once. If you cannot contact your doctor, go to the nearest accident and emergency department. Take along any tablets that are left, including the container and the carton, so that the hospital staff can easily tell what you have taken.

If you forget to take Ranolazine Wockhardt

If you forget to take a dose, take it as soon as you remember unless it is nearly time (less than 6 hours) to take your next dose. Do not take a double dose to make up for a forgotten dose.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

You should stop taking Ranolazine Wockhardt and see your doctor immediately if you experience the following symptoms of angioedema, which is a rare condition but can be severe:

  • swollen face, tongue, or throat
  • difficulty swallowing
  • hives or difficulty breathing.

Tell your doctor if you experience common side effects such as dizziness or feeling sick or vomiting. Your doctor may lower your dose or stop treatment with Ranolazine Wockhardt.

Other side effects you may experience include the following:

Common side effects (occur in 1 to 10 users in 100) are:

  • constipation
  • dizziness
  • headache
  • feeling sick, vomiting
  • feeling weak.

Uncommon side effects (occur in 1 to 10 users in 1,000) are:

  • altered sensation
  • anxiety, difficulty sleeping, confusional state, hallucination
  • blurred vision, visual disturbance
  • changes in sensation (touch or taste), tremor, feeling tired or sluggish, sleepiness or drowsiness, faint or fainting, dizziness upon standing
  • dark urine, blood in urine, difficulty urinating
  • dehydration
  • difficulty breathing, cough, nose bleed
  • double vision
  • excessive sweating, itching
  • feeling swollen or bloated
  • hot flushes, low blood pressure
  • increases in a substance called creatinine or increases in urea in your blood, increase in blood platelets or white blood cells, changes in ECG heart tracing
  • joint swelling, pain in extremities
  • loss of appetite and/or weight loss
  • muscle cramp, muscle weakness
  • ringing in the ears and/or feeling a spinning sensation
  • stomach pain or discomfort, indigestion, dry mouth, or wind.

Rare side effects (occur in 1 to 10 users in 10,000) are:

  • a lack of ability to urinate
  • abnormal laboratory values for liver
  • acute kidney failure
  • change in sense of smell, numbness in mouth or lips, impaired hearing
  • cold sweat, rash
  • coordination problems
  • decrease in blood pressure upon standing
  • decreased or loss of consciousness
  • disorientation
  • feeling of coldness in hands and legs
  • hives, allergic skin reaction
  • impotence
  • inability to walk due to imbalance
  • inflammation of pancreas or intestine
  • loss of memory
  • throat tightness
  • low level of sodium in the blood (hyponatremia) which can cause tiredness and confusion, muscle twitching, cramps and coma.

Not known side effects (frequency cannot be estimated from the available data) are:

  • myoclonus (involuntary contractions of muscles).

    Reporting of side effects

    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:

    www.mhra.gov.uk/yellowcard

    or search for MHRA Yellow Card

    in the Google Play or Apple

    App Store.

    By reporting side effects you

    can help provide more

    information on the safety of

    this medicine.

5. How to store Ranolazine Wockhardt

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after “EXP”. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Ranolazine Wockhardt contains

The active substance in Ranolazine Wockhardt is ranolazine. Each tablet contains 375mg, 500mg, or 750mg ranolazine. The other ingredients are: hypromellose, magnesium stearate, methacrylic acid-ethyl acrylate copolymer and microcrystalline cellulose.

Depending on the tablet strength, the tablet coatings also contain:

375mg tablet: titanium dioxide, macrogol, polysorbate 80 and Blue #2/Indigo Carmine Aluminium Lake (E132).

500mg tablet: polyvinyl alcohol, titanium dioxide, macrogol, talc, iron oxide yellow (E172) and iron oxide red (E172).

750mg tablet: titanium dioxide, glycerol triacetate, lactose monohydrate, Blue #1/Brilliant Blue FCF Aluminium Lake (E133) and Yellow #5/Tartrazine Aluminium Lake (E102).

What Ranolazine Wockhardt looks like and contents of the pack

Ranolazine Wockhardt prolonged-release tablets are oval shaped tablets.

The 375mg tablets are pale blue, oval shaped biconvex tablet debossed with ‘R3’ on one side and plain on other side.

The 500mg tablets are pale yellow, oval shaped biconvex tablet debossed with ‘R5’ on one side and plain on other side.

The 750mg tablets are pale green, oval shaped biconvex tablet debossed with ‘R7’ on one side and plain on other side.

Tablets are supplied in blister packs consisting of PVC/PVDC/Aluminium blisters which are further packed into a carton. Each carton contains 30, 60 or 100 tablets. Not all pack-sizes may be marketed.

Marketing Authorisation Holder

Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, UK

Manufacturer

CP Pharmaceuticals Ltd., Ash Road North, Wrexham, LL13 9UF, UK

Other Formats

To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:

0800 198 5000 (UK only).

Please be ready to give the following information:

Product NameReference Number
Ranolazine Wockhardt 375mg Prolonged-Release Tablets29831/0768
Ranolazine Wockhardt 500mg Prolonged-Release Tablets29831/0769
Ranolazine Wockhardt 750mg Prolonged-Release Tablets29831/0770

This is a service provided by the Royal National Institute of Blind People.

This leaflet was last revised in 02/2026.

pg2/2

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 29831/0770

Last revision stated in the text: February 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Ranolazine Wockhardt 750 mg prolonged-release tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Ranolazine
Strength 750 mg
Pharmaceutical form Modified-release tablet
Pale green, oval shaped biconvex tablet debossed with ‘R7’ on one side and plain on other side.
Tablet dimensions: approximately 19.10 mm x 9.30 mm.
How is it taken Oral
Excipients Microcrystalline cellulose, Methacrylic acid-ethyl acrylate copolymer (1:1), Hypromellose, Magnesium stearate, Lactose monohydrate, Titanium dioxide, Triacetin, FD&C Blue #1 (Brilliant blue FCF Aluminum lake) (E133), FD&C Yellow#5 (Tartrazine Aluminum lake) (E102)
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Other cardiac preparations
  1. C Cardiovascular system drugs
    1. C01 Cardiac therapy drugs
      1. C01E Other cardiac preparations
        1. C01EB Other plain cardiac preparations
          1. C01EB18 ranolazine
Marketing authorisation PL 29831/0770 (first authorised 24 August 2026)
Marketing authorisation holder Wockhardt UK Ltd.
Codes BNF 02060300

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.